Dosimetric impact of a frame-based strategy in stereotactic radiotherapy of lung tumors

References

• Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, . Stereotactic body radiation therapy: The report of AAPM Task Group 101. Med Phys 2010;37:4078–101.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Hoyer M, Wennberg B, Gagliardi G, Lax I, . Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009;27:3290–6.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, . Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010;303:1070–6.
   PubMed Web of Science ®Google Scholar
• Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, . Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 2009;75:677–82.
   PubMed Web of Science ®Google Scholar
• McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010–5.
   PubMed Web of Science ®Google Scholar
• Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, . Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427–31.
   PubMed Web of Science ®Google Scholar
• Martin A, Gaya A. Stereotactic body radiotherapy: A review. Clin Oncol 2010;22:157–72.
   PubMed Web of Science ®Google Scholar
• Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, . Extracranial stereotactic radioablation – Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946–55.
   PubMed Web of Science ®Google Scholar
• Lagerwaard FJ, Haasbeek CJA, Smit EF, Slotman BJ, Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:685–92.
   PubMed Web of Science ®Google Scholar
• Haasbeek CJA, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S. Stage I nonsmall cell lung cancer in patients aged > = 75 years outcomes after stereotactic radiotherapy. Cancer 2010;116:406–14.
   PubMed Web of Science ®Google Scholar
• Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, . Stereotactic body radiation therapy: A novel treatment modality. Nature Rev Clin Oncol 2010;7:44–54.
   PubMed Web of Science ®Google Scholar
• Baumann P, Nyman J, Lax I, Friesland S, Hoyer M, Rehn Ericsson S, . Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006;45:787–95.
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Naslund I, Svanström R. Stereotaxic radiotherapy of malignancies in the abdomen – methodological aspects. Acta Oncol 1994;33:677–83.
   PubMed Web of Science ®Google Scholar
• Lax I, Larsson D, Näslund I, Naslund I. Extracranial stereotactic radiosurgery of localized target. J Radiosurg 1998; 1:135–48.
   Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotaxic high-dose fraction radiation-therapy of extracranial tumors using an accelerator – clinical-experience of the first 31 patients. Acta Oncol 1995;34:861–70.
   PubMed Web of Science ®Google Scholar
• Ding GX, Duggan DM, Lu B, Hallahan DE, Cmelak A, Malcolm A, . Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys 2007;34:2985–94.
   PubMed Web of Science ®Google Scholar
• Franks KN, Purdie TG, Dawson LA, . Incorporating heterogeneity correction and 4DCT in lung stereotactic body radiation therapy (SBRT): The effect on target coverage, organ-at-risk doses, and dose conformity. Med Dosim 2010;35:101–7.
   PubMedGoogle Scholar
• Xiao Y, Papiez L, Paulus R, Timmerman R, Straube WL, Bosch WR, . Dosimetric evaluation of heterogeneity corrections for Rtog 0236: Stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009;73:1235–42.
   PubMed Web of Science ®Google Scholar
• Pearson M, Atherton P, McMenemin R, McDonald F, Mazdai G, Mulvenna P, . The implementation of an advanced treatment planning algorithm in the treatment of lung cancer with conventional radiotherapy. Clin Oncol 2009;21:168–74.
   Google Scholar
• Aarup LR, Nahum AE, Zacharatou C, Juhler-Nøttrup T, Knöös T, Nyström H, . The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: Implications for tumour coverage. Radiother Oncol 2009;91:405–14.
   PubMed Web of Science ®Google Scholar
• Korreman S, Rasch C, McNair H, Dirk Verellen D, Uwe Oelfke E, Philippe Maingon F, . The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: A practical and technical review and guide. Radiother Oncol 2010;94:129–44.
   PubMed Web of Science ®Google Scholar
• Bissonnette JP, Purdie TG, Higgins JA, Li W, Bezjak A. Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys 2009;73:927–34.
   PubMed Web of Science ®Google Scholar
• Worm ES, Hansen AT, Petersen JB, Muren LP, Præstegaard LH, Høyer M. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung. Acta Oncol 2010;49:1177–83.
   PubMed Web of Science ®Google Scholar
• Nyman J. SPACE - Stereotactic precision and conventional radiotherapy evaluation. A multicenter randomized phase II study of stereotactic hypofractionated radiotherapy with body frame versus conventionally fractionated radiotherapy for stage I medically inoperable non-small cell lung cancer 2006. [cited 2011 Sep 9]. Available from: www.nlcg.no/uploads/space_060717.doc
   Google Scholar
• Galerani AP, Grills I, Hugo G, Kestin L, Mohammed N, Chao KK, . Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2010;78:1571–8.
   PubMedGoogle Scholar
• Grills IS, Hugo G, Kestfn LL, Galerani AP, Chao KK, Wloch J, . Image-guided radiotherapy via daily online cone-beam CT substantially reduces margin requirements for stereotactic lung radiotherapy. Int J Radiat Oncol Biol Phys 2008;70:1045–56.
   PubMed Web of Science ®Google Scholar
• Guckenberger M, Wilbert J, Krieger T, Richter A, Baier K, Meyer J, . Four-dimensional treatment planning for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2007;69:276–85.
   PubMed Web of Science ®Google Scholar
• Hof H, Rhein B, Haering P, Kopp-Schneider A, Debus J, Herfarth K. 4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: Comparison with a conventional technique using individual margins. Radiother Oncol 2009;93:419–23.
   PubMedGoogle Scholar
• Nakamura M, Narita Y, Matsuo Y, Narabayashi M, Nakata M, Yano S, . Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe. Med Phys 2008;35:4142–8.
   PubMedGoogle Scholar
• Vergalasova I, Maurer J, Yin FF. Potential underestimation of the internal target volume (ITV) from free-breathing CBCT. Med Phys 2011;38:4689–99.
   PubMedGoogle Scholar
• Stroom J, Blaauwgeers H, van Baardwijk A, Boersma L, Lebesque J, Theuws J, . Feasibility of pathology- correlated lung imaging for accurate target definition of lung tumors. Int J Radiat Oncol Biol Phys 2007;69:267–75.
   PubMedGoogle Scholar